Achieve Life Sciences, Inc.
ACHV· Nasdaq
ACHVAchieve Life Sciences, Inc.
Filed May 13, 2025 · 10-Q · 43 days after period end · 0000950170-25-069806
| Metric | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Net Income | -$12.83M | -$6.49M | -$8.99M | -$7.57M |
| EPS Diluted | -$0.37 | -$0.26 | -$0.50 | -$0.80 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Achieve Life Sciences, Inc. · CIK 949858 · Engraved from SEC EDGAR
ended Mar 31, 2025 · filed May 13, 2025 · 43 d after period end
